
Vaginal Dryness, Painful Sex and UTIs After Menopause: GSM and Vaginal Estrogen Explained
Vaginal dryness after menopause, along with burning, painful sex, urinary urgency and recurring UTIs, is part of a common condition called genitourinary syndrome of menopause (GSM). It's caused by low estrogen in the tissues of the vagina, vulva and bladder. Unlike hot flashes, GSM usually doesn't improve on its own and often gets worse over time. It's very treatable: moisturizers and lubricants help mild symptoms, and low-dose vaginal estrogen is a highly effective, low-risk treatment for most women. In November 2025, the FDA announced removal of the long-standing "black box" warnings from menopause hormone therapy labels, a change that covered vaginal estrogen too.
Hot flashes get the headlines. But for many women, the menopause symptom that affects daily life the most is one they rarely mention: vaginal dryness, discomfort, or bladder problems that just keep coming back. Studies suggest at least half of postmenopausal women experience these symptoms, yet many never bring them up, and many clinicians never ask.
Interest is growing. Google searches for "vaginal estrogen" climbed steadily from 2017 to 2023. Here's what causes GSM, how it's treated, and what you should know about vaginal estrogen safety.

What is genitourinary syndrome of menopause (GSM)?
Genitourinary syndrome of menopause, or GSM, is the medical name for changes to the vulva, vagina, urethra and bladder caused by low estrogen. You may also hear the older term vaginal atrophy. Estrogen keeps these tissues thick, stretchy, moist and well supplied with blood. As estrogen falls in perimenopause and after menopause, the tissues become thinner, drier and more fragile, and the vagina's healthy bacterial balance changes.
GSM can start during perimenopause and often becomes more noticeable in the years after your last period. Women who've had breast cancer treatment, ovary removal or certain medications may notice it earlier or more severely.
Signs of GSM and vaginal dryness after menopause
Vaginal dryness, itching, burning or irritation
Painful sex, or light bleeding after sex
Lower libido or less arousal, often linked to discomfort
Urinary urgency or needing to go more often
Burning when you urinate, even without an infection
Recurrent urinary tract infections (UTIs)
Discomfort when sitting, exercising or wearing tight clothing
See how GSM fits with other changes in our perimenopause symptom checklist.
UTIs after menopause: why they keep coming back
Recurrent UTIs after menopause are a common and often overlooked part of GSM. When estrogen falls, the vagina's protective lactobacilli bacteria decline and the vaginal pH rises, making it easier for UTI-causing bacteria to take hold. The urethra and bladder lining also become thinner.
The good news: for postmenopausal women with recurrent UTIs, vaginal estrogen can lower the chance of future infections. The American Urological Association recommends that clinicians offer vaginal estrogen to peri- and postmenopausal women with recurrent UTIs to reduce that risk. If you're on repeated courses of antibiotics, it's worth asking about.

Treatment options for vaginal dryness after menopause
Non-hormonal options: moisturizers and lubricants
For mild symptoms, these are a good first step:
Vaginal moisturizers are used regularly, every few days, to keep tissues hydrated, much like a moisturizer for your skin.
Lubricants are used during sex to reduce friction and discomfort. Water-based and silicone-based options are widely available.
Gentle care: avoid scented soaps, douches and harsh products that can irritate thin tissues.
Pelvic floor physical therapy can help when painful sex has led to muscle tension or pain.
Moisturizers and lubricants ease symptoms but don't reverse the underlying tissue changes. If symptoms continue, it's time to consider treatment.
Vaginal estrogen
Low-dose vaginal estrogen is the most effective treatment for moderate to severe GSM. It delivers a small amount of estrogen directly to the tissues that need it, restoring moisture, thickness and a healthy bacterial balance. Most women notice improvement within a few weeks, with full benefit after about two to three months.
Form | How it's used | Good to know |
Vaginal estrogen cream | Applied with an applicator, usually a few times a week after a starting phase | Flexible dosing; can also be applied to the vulva |
Vaginal tablet or insert | Small tablet or softgel placed in the vagina, usually twice a week after a starting phase | Less messy; very low dose |
Vaginal ring | Soft, flexible ring replaced every three months | Low maintenance; nothing to remember week to week |
Other prescription options
Vaginal DHEA (prasterone): a nightly vaginal insert that the body converts into small amounts of estrogen and testosterone in the vaginal tissue.
Ospemifene: a daily pill that acts like estrogen on vaginal tissue, for painful sex caused by menopause.
Systemic hormone therapy (patch, gel or pill) helps GSM too, and is often used when hot flashes are also a problem. Some women need vaginal estrogen in addition. Read our guide to hormone replacement therapy.
A note on vaginal laser treatments: they're widely marketed, but the FDA has warned about promoting energy-based devices for these symptoms, and evidence on long-term benefit and safety is still limited.
Is vaginal estrogen safe?
For most women, yes. Low-dose vaginal estrogen works mainly where it's applied, and very little reaches the bloodstream. Research has not shown an increased risk of breast cancer, blood clots, stroke or heart disease with low-dose vaginal estrogen.
For years, though, vaginal estrogen carried the same boxed warning as stronger systemic hormone therapy, which scared many women away. In November 2025, the FDA announced removal of the black box warnings about heart disease, breast cancer and dementia from menopause hormone therapy labels, a change Harvard Health noted applies to vaginal estrogen as well.
Points to discuss with your clinician:
Breast cancer history: if you've had breast cancer, especially if you take an aromatase inhibitor, talk with your oncology team. Non-hormonal options come first, but low-dose vaginal estrogen may be considered when they aren't enough.
Bleeding: any vaginal bleeding after menopause should be checked before starting treatment, and reported if it happens during treatment.
Progestogen: women using low-dose vaginal estrogen generally don't need to add a progestogen, but ask your clinician about your situation.

Why it's worth speaking up
Many women assume vaginal dryness, painful sex or frequent UTIs are just part of getting older, or feel embarrassed to mention them. Others have their bladder symptoms treated over and over with antibiotics while the underlying cause is missed. That pattern of treating symptoms one at a time is the heart of Dr. Adam Sewell's book Misdiagnosed. GSM is common, it's a medical condition, and it's treatable at any age. Learn more about our approach to menopause care.
When to see a clinician
Book a visit if vaginal dryness, discomfort or urinary symptoms bother you or affect your relationships or daily life. See someone promptly for any bleeding after menopause, a UTI with fever, back pain or vomiting, or symptoms that don't improve with treatment, since other conditions can look like GSM.
Frequently asked questions
What causes vaginal dryness after menopause?
Vaginal dryness after menopause is caused by low estrogen, which makes the tissues of the vagina and vulva thinner, drier and less elastic. It's part of a condition called genitourinary syndrome of menopause (GSM).
What is genitourinary syndrome of menopause (GSM)?
GSM is the medical name for vaginal, vulvar and urinary changes caused by low estrogen, including dryness, burning, painful sex, urinary urgency and recurrent UTIs. It was previously called vaginal atrophy, and it usually worsens without treatment.
Is vaginal estrogen safe?
For most women, low-dose vaginal estrogen is considered safe and effective, because very little reaches the bloodstream. Research has not shown higher risks of breast cancer, blood clots or stroke. Women with a history of breast cancer should discuss it with their oncology team.
Did the FDA remove the black box warning on vaginal estrogen?
Yes. In November 2025, the FDA announced removal of the boxed warnings about heart disease, breast cancer and dementia from menopause hormone therapy labels, a change that applies to vaginal estrogen products as well.
Can vaginal estrogen prevent UTIs after menopause?
Yes. For postmenopausal women with recurrent UTIs, vaginal estrogen helps restore healthy vaginal bacteria and can reduce the risk of future infections. The American Urological Association recommends offering it for this purpose.
What's the difference between a vaginal moisturizer and a lubricant?
A vaginal moisturizer is used regularly, every few days, to keep tissues hydrated. A lubricant is used during sex to reduce friction. Both ease symptoms of vaginal dryness but don't reverse the tissue changes the way vaginal estrogen can.
Ready for answers that fit?
You don't have to live with discomfort or keep cycling through antibiotics. Start with our free Whole-Picture Check, or get started with a licensed clinician you can talk to openly.
This article is for education only and isn't a substitute for individualized medical care. Prescription treatments require a review of your personal health history.
Sources
Harvard Health: FDA removes menopause hormone therapy black box warnings
US Department of Health and Human Services: FDA initiates removal of black box warnings from menopausal hormone therapy products (Nov 2025)
International Journal of Impotence Research, 2025: Google Trends interest in vaginal estrogen, 2017–2023
The Menopause Society: The 2020 genitourinary syndrome of menopause position statement, Menopause, 2020
American Urological Association / CUA / SUFU: Recurrent Uncomplicated Urinary Tract Infections in Women guideline, 2019 (amended 2022)
ACOG: Treatment of urogenital symptoms in individuals with a history of estrogen-dependent breast cancer, Clinical Consensus, 2021
US FDA: Statement on energy-based devices for vaginal "rejuvenation," 2018